On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

An Ozempic warning has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for any women taking ...

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic ...

Weight-loss jabs could stop the contraceptive pill working and lead to unwanted pregnancies, health officials have warned.

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

TD Cowen analysts trimmed the price target for Eli Lilly and Company (NYSE:LLY) from $1,050 to $960, while reiterating a Buy ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.